Answers are grounded in this paper and cite their sources.
Editorial introduces advances in redox biology and targets for therapeutics, highlighting their potential to transform pharmacology.
Redox signalling governs key physiological and pathological processes, offering diverse therapeutic targets across disease contexts. This editorial introduces a special issue of the British Journal of Pharmacology highlighting recent advances in redox biology, including novel small molecules, non‐canonical nitric oxide and hydrogen sulfide pathways, epigenetic modulation and immune regulation. Together, these contributions illustrate the translational potential of redox‐targeted pharmacology and outline future directions for innovation in the field.
No takes yet. Share an insight, caveat, or question.
Cortese‐Krott et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: